Oncology

Latest News

Photo courtesy of SpringWorks Therapeutics
FDA Approves First Treatment for Rare Noncancerous Tumors

November 28th 2023

Ogsiveo will be available within five to 10 business days to treat patients with desmoid tumors. It will launch with a price of $29,000 for a 30-day supply.

Janssen Submits Supplemental Application for Rybrevant in NSCLC
Janssen Submits Supplemental Application for Rybrevant in NSCLC

November 21st 2023

FDA to Hold Advisory Meeting for Abecma in Earlier Treatment of Multiple Myeloma
FDA to Hold Advisory Meeting for Abecma in Earlier Treatment of Multiple Myeloma

November 21st 2023

FDA Approves First-in-Class Therapy for HR Positive Breast Cancer
FDA Approves First-in-Class Therapy for HR Positive Breast Cancer

November 20th 2023

Bayer Recalls One Lot of Vitrakvi Because of Contamination
Bayer Recalls One Lot of Vitrakvi Because of Contamination

November 20th 2023

Latest CME Events & Activities

More News

© 2023 MJH Life Sciences

All rights reserved.